1. Survival probability (%)
Supplemental Fig. 1
Kaplan-Meier curves demonstrating rates of the combined endpoint death/MI over a median follow-up period of 271 days when elevations of either cTnI or hs-cTnT were present.
100
100 95 95
hs-cTnT<99th 90 90
cTnI<99th 85 85 80 80
Survival probability (%)
hs-cTnT≥99th 75 75
cTnI≥99th 70 70
Logrank 28,99
p<0.0001
Logrank 32,50
p<0.0001 65 65 60 60 55 55
200
400
600
800
1000
1200
200
400
600
800
1000
1200
Time
Time
Number at risk
Number at risk
cTnI<99th:
hs-cTnT<99th:
393
319
117 35 14 4
306
252 84 27 11 5
cTnI≥99th:
hs-cTnT≥99th:
984
739
266
103 49 9 1
1071
806
299
111 52 8 1
Mueller M et al. - Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome, Clinical Research in Cardiology